{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2009"],"condition":["Chemotherapy-induced Peripheral Neuropathy","Pain","Peripheral Nervous System Diseases","Colorectal Cancer","Myeloma","Breast Cancer","Cancer"],"disease":["Chemotherapy-induced Peripheral Neuropathy","Pain","Peripheral Nervous System Diseases","Colorectal Cancer","Myeloma","Breast Cancer","Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2080972"],"study_start_month":["11"],"keyword":["Symptom measurement tools","Neuropathic symptom tool","Colorectum Cancer","Platinum agents","QST","Bortezomib","Oxaliplatin","Quantitative Sensory Testing","Colorectal disease","CIPN","Taxanes","Cisplatin"],"repository":["ECRIN MDR"],"study_status":["Withdrawn"],"additional_accession":[]},"is_claimable":false,"name":"Chemotherapy-Induced Peripheral Neuropathy Survey","description":"The goal of this research study is to learn more about pain and other symptoms that patients may experience while receiving chemotherapy treatment with platinum agents, taxanes, and/or bortezomib.","dates":{"creation":"2009-11-15"},"accession":"2080972","cross_references":{"ClinicalTrials___gov":["NCT01016028"]}}